Healthcare Technologies at EPSRC ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Hannah Maytum...
-
Upload
blake-pierce -
Category
Documents
-
view
215 -
download
0
Transcript of Healthcare Technologies at EPSRC ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Hannah Maytum...
Healthcare Technologies at EPSRC
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL
Hannah Maytum12/05/11
Contents
Delivery Plan including outcomes from SR
What is Healthcare Technologies?
Brief Overview of Healthcare Portfolio
Plans for 2011/2012
The Future
Delivery and Implementation Plans
Delivery Plan for 2011 - 2015
Our Delivery Plan was published on the Web in December 2010
It sets out our high level plans for the next spending review period, 2011 – 2015
It follows on from the Strategic Plan which was published in spring 2010
How we see the futureOur strategy has
3 clear goals
Delivering impact
Shaping capability
Developing leaders
Our Three Strategic Plan Goals
1. Delivering Impact
Embedding impact throughout our portfolio by creating an environment in which it arises naturally, in whatever form, from the knowledge base.
This means:researchers will be asked to consider
Impact when they apply for funding and you will be able to ask for resources in
order to achieve this Impact.
Our Three Strategic Plan Goals
2. Shaping Capability
Ensuring we have the right people, with the right resource, in the right places to deliver the highest quality long-term research in areas where the UK leads internationally and where there is current or future national need.
This means:we will be making informed judgements about where our funding should go and so some areas will receive more funding
and some will receive less.
Our Three Strategic Plan Goals
3. Developing Leaders
Nurturing the visionary leaders who set research agendas and inspirational team leaders who act as role models.
This means:working closely with the community to support and promote leadership role models who can inspire and integrate
efforts of their peers to achieve greater impact from our investment.
Information about funder to sponsor changes
We are changing our approach to our relationship with our grant holders. We intend to:
Provide direction to researchers from strategic advice
Obtain regular feedback from sponsored researchers and use it to inform future funding
Secure commitment and engagement from our researchers to achieve our goals
Behave as an advocate for engineering and physical sciences.
This change in working is not completely new – we already have this relationship with a lot of
our larger investments .
Resource Capital Admin
“Flat cash” & ring fenced
Overall reduction ~ 50%
Overall reduction ~ 34 % with inflation
Yr 1 fixed, Yrs 2 – 4 indicative
Yr 1 fixed, Yrs 2 – 4 indicative
Total S & R £18.3bn
HEFCE £6.7bn
RCs £10.4bn
Total S & R £1.9bn
RCs £800m
EPSRC £3bn (by end of CSR 3% cash reduction, 12% reduction with inflation)
EPSRC £116m (excludes HPC funding from the large facilities capital fund)
EPSRC £62m (Near Cash)
Spending Review Allocation (2011/12 – 2014/15)
Resource Baseline Allocation by mechanism by financial year
2010/11£M
2011/12
£M
2012/13
£M
2013/14
£M
2014/15
£M
Near Cash Programme Resource
Manufacturing the Future
74 78 79 82 83
Energy 104 109 109 109 112
Digital Economy 24 26 26 27 27
Healthcare Technologies
74 76 76 76 76
Other themes (LWEC, GU)
18 17 17 17 17
National capability
458 427 412 406 400
ETI 8 15 17 19 21
Programme operations
12 12 12 12 12
Net Near Cash Programme Resource Expenditure
771 760 748 748 748
Programme Depreciation 10 11 11 8 7
Programme Resource Expenditure 781 771 759 756 755
Programme Capital Expenditure 49 46 35 25 25
Total Programme Expenditure 830 817 794 781 780
Planned Expenditure by Theme
Protected: Manufacturing the Future; Energy, DE, Healthcare.
Already committed to ETI programme.
Changes to look out for:
Equipment sharing
Capital funding for equipment
Stage-gating of funding
Review of Centres for Doctoral Training
Statement of expectation for Postgraduate Training
Wakeham efficiencies - RCUK briefing for universities (PVC Research and Finance Directors) was on 18th March
What is Healthcare Technologies?
What is Healthcare Technologies?Healthcare Technologies describes everything that EPSRC funds which is Healthcare relevant.
This does not just mean widgets and gadgets!
Healthcare Technologies is all about the capabilities which advance tools, techniques and technologies relevant to health
It covers everything from medical engineering, drug delivery, modelling, ICT for health etc and is very much an outcome focussed view of the portfolio.
We are aiming to describe our portfolio in a way that makes sense to the community and other funders alike.
By describing our portfolio effectively, we will be able to make informed decisions about where future funding will be targeted.
EPSRC Unique Position in Healthcare:Sponsoring basic research capabilities that create new
techniques and technologies which can:
• Advance the prevention, diagnosis, treatment and management of health conditions, for example through new imaging technology and drug delivery techniques
• Enable greater biomedical understanding and pull-through to therapy. Examples include modelling techniques and scale-up technologies
• Have the potential to transform future health delivery systems, such as information-driven healthcare.
Underpins Healthcare Sector (e.g. Pharmaceutical & Medical Technology industries & the NHS) – important for economic growth and social wellbeing in the UK
Research Councils and Technology Strategy Board
1 4 7 9532 6 8
From Bench to Bedside and Back Again
Needs identification & knowledge
creation
Solution development
Validating concept
Investment validation
Clearance and trials
Launch and evaluation
Technology Readiness Levels
EPSRCTSB
Healthcare Technologies going forward…Remit:
Healthcare technologies – capability, tools, techniquesBasic / transformative research that is high quality and world leading
Drivers:Focus to build critical mass around UK strengths Maximise industrial and user involvement / relevance (partnership)
So it’s about: changing how we work – moving to more of a ‘sponsor’ approachShaping our portfolio to maximise benefit / impact
It’s not about:Large new funding for healthcareChanging our remit – we are not moving to funding more applied research, still basic
Brief Overview of Healthcare Portfolio
Assistive Techs
Regen Med
Medicines
Design & Techs for
Public Health
Techniques for Biomedical Understanding
Diagnostics
Therapeutics
Digital Health Techs
Healthcare Technology Areas
Regenerative Medicine as an Example
Regen Med
Assistive Techs
Medicines
Design & Techs
for Public Health
Techniques for Biomedical
Understanding
Diagnostics
Therapeutics
Digital Health Techs
Non-linearSystems
Polymer Materials
Biomaterials & Tissue
Engineering
Analytical Science
ProcessSystems,
Components & Integration
Mathematics
Physical Sciences
Engineering
Healthcare Technology Area Definitions
ASSISTIVE TECHS
Technologies that employ the use of services/devices to help those with disabilities and age
related conditions
DESIGN & TECHS for PUBLIC HEALTH
Involves the design of the built environment and technologies to improve health and prevent
injury/disease
DIAGNOSTICS
Design and development of devices, instrumentation and technologies for analysis and diagnosis of conditions and
diseases
5%
14%
29%
Healthcare Technology Area Definitions
DIGITAL HEALTH TECHS
MEDICINES
Collection, processing and management of health
information
The underpinning chemistry, novel drug delivery and
manufacturing of medicines
8.5%
14%
Healthcare Technology Area Definitions
REGEN MED
TECHNIQUES for BIOMEDICAL
UNDERSTANDING
THERAPEUTICS
Study and development of artificial organs, specially grown tissues and cell (including stem cells), laboratory made compounds, and combinations of these approaches for treating injuries/disease
Modelling, characterising and sensing to understand areas of biomedical interest,
Includes materials understanding, modelling of things such as blood flow, understanding chemistry and biology
behind sensors
Design and development of devices, instrumentation and technologies for the treatment of conditions and
diseases
11%
11.5%
7%
Funding of Healthcare Technology Areas
0
5
10
15
20
25
30
5
14
29
8.5
1411 11.5
7
Plans for 2011/2012and
The Future
Funding Opportunities in 2011/12
TSB led Regenerative Medicine Tools and Techniques Competition – we are co-funding but the call is now closed, grants announced around September 2011
Joint EPSRC/TSB Grand Challenge on Nano-enabled diagnostics and therapies in Autumn 2011 (led by TSB, project must be business led)
Partner in the National Prevention Research Initiative Phase 4 call led by MRC, this call is currently open
Funding Opportunities in 2011/12
MRC led e-Health call planned for Summer 2011 to fund 5 e-Health Informatics Research Centres, we are a funding partner for this
Standard EPSRC research base funding is still available
Fellowships are changing – new strategy to be launched in Summer 2011 (current call for start in October 2011 is unaffected)
Call Updates From EPSRC
http://fd.epsrc.ac.uk/EmailAlert/
Future Activities
Review of Centres for Doctoral Training (happening at the moment)
Consultation with key stakeholders in Healthcare in late 2011
Joint scoping of the medical imaging portfolio with MRC
Future Activities
Continuing partnering in Lifelong Health and Wellbeing, led by MRC, including scoping 4 themes :
1. Achieving good cognitive function and mental wellbeing in later life
2. Promoting physical health in older age3. Enhancing mobility and independence in an
ageing population4. Extending healthy working lives
EPSRC will be looking at data relating to area 3 in the near future.
The Healthcare Technologies Team at EPSRC
Dr Rachel BishopHead of Healthcare
Technologies
Dr Claire WagstaffeSenior Portfolio
Manager
Dr Nicola GoldbergPortfolio Manager
Ms Linda SayersPortfolio Manager
Dr Hannah MaytumPortfolio Manager
Mr Eric DoughertyAdmin Support for
Healthcare Technologies
Miss Elaine MeskhiYear in Industry Student
Emails addresses are [email protected]
Hannah [email protected]